Skip to main content

Vestal Point Capital, LP

Position in NRIX — Nurix Therapeutics, Inc.

CIK 1974915 NEW YORK, NY

Position in NRIX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$195,293,000
+$94,543,000 QoQ
Shares Held
8,050,000
+23.8% QoQ
Ownership
7.76%
of shares outstanding
% of Portfolio
4.56%
of 13F equity value
Holder Rank
#2
of 210 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NRIX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Vestal Point Capital, LP holds $2,824,321,683 across 51 Biotechnology names. NRIX ranks #4 (6.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 NRIX
Nurix Therapeutics, Inc.
This page
8,050,000 $195,293,000

All Filings in NRIX

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $195,293,000 8,050,000
2026-06-30 $195,293,000 8,050,000
2026-03-31 $100,750,000 6,500,000
2025-12-31 $88,969,300 4,690,000
2025-09-30 $32,109,000 3,475,000
2025-06-30 $22,780,000 2,000,000
2025-03-31 $13,371,557 1,125,552
2024-12-31 $9,137,400 485,000
2024-09-30 $9,549,750 425,000
2024-06-30 $10,435,000 500,000